Navigation Links
Blending conference translates substance abuse research into practice
Date:4/16/2012

Experts will share the latest clinical research with addiction treatment professionals, healthcare providers, policy makers, and others during the April 19th Blending Conference in Atlanta, Georgia. The program is supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, in collaboration with the American Society of Addiction Medicine Annual Medical-Scientific Conference as part of an ongoing initiative to accelerate research findings into practice.

WHAT: Blending Initiative: Accelerating Knowledge Exchange in Substance Abuse Treatment
www.seiservices.com/nida/blending2012/Default.aspx

WHEN: April 19, 2012
8 a.m. 5 p.m.

WHERE: Hilton Atlanta Hotel
255 Courtland St. NE
Atlanta, GA 30303

This year's program includes:

  • Making motivational interviewing techniques accessible to primary care;
  • New approaches to pharmacotherapy for substance use disorders;
  • Screening, brief intervention, referral to treatment (SBIRT): implementation for primary care and/or emergency departments; and
  • HIV testing and intervention in integrated treatment settings.


'/>"/>

Contact: NIDA Press Office
media@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
Source:Eurekalert

Page: 1

Related medicine news :

1. Custom Blending Announces New Brand Launch: Harmony Valley Vegetarian Mixes at Fancy Food Show, New York City, June 27-29, 2010
2. NJ stroke researchers report advances in spatial neglect research at AAN Conference
3. Elsevier organizes label-free technologies conference
4. Conference explores ethical dimension of NHS
5. Kessler Foundation neuroscientist addresses 2nd Annual TBI Conference in Washington DC
6. Kessler Foundation researchers present at DC Conference on Race, Ethnicity and Disabilities
7. Experts in pediatric heart disease present research at Cardiology 2012 conference
8. TGen hosts international conference for leading pediatric cancer researchers, foundations
9. SFU hits hot buttons at 2012 AAAS conference
10. Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC
11. Kessler Foundations John DeLuca, Ph.D., conducts national MS Society teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... , ... May 06, 2016 , ... ... AsedaSciences® in an upcoming episode, airing third quarter 2016, via Discovery Channel. Dates ... of becoming a leader in optimized drug discovery through innovative cellular analysis. In ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... does to reduce fat areas around the body, is the most popular among ... results just released make perfect sense to cosmetic surgeon Dr. Richard Buckley, medical ...
(Date:5/6/2016)... Grants Pass, OR (PRWEB) , ... May 06, 2016 , ... ... the eyes. In other seasons, when the weather is too cold, dry or hot, ... weather, the eyes can actually absorb moisture from the surrounding air. There’s only one ...
(Date:5/6/2016)... ... May 06, 2016 , ... Online HR/benefits platforms offer a range ... game for traditional brokers and health plans. “ The Rapid Emergence of Online Benefits ... Atlantic Information Services, Inc. (AIS), will offer an accurate picture of online benefits today, ...
(Date:5/6/2016)... ... May 06, 2016 , ... From May 4 to 6, ... members the unique opportunity to learn more about Signia’s technology and the successful business ... “It is our priority to see practices succeed in this highly competitive industry,” said ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... , May 6, 2016 ... of liver disorders along with rise in obesity ... drugs in the coming few years. The NASH ... last five years on account of rising number ... is a large, un-tapped market with no FDA ...
(Date:5/5/2016)... -- Replikins Ltd. today reported initial promising results in animal trials of its Zika vaccine ... ... ... ... on Pubmed. The analysis identified the highest gene Replikin Counts in Zika history back ...
(Date:5/5/2016)...  Endo International plc (NASDAQ: ENDP ... Lortie , President, U.S. Branded Pharmaceuticals, has decided ... appointment of a successor. Mr. Lortie joined Endo ... with responsibility for all strategic, commercial and operational ... development, commercial operations, managed markets, manufacturing, supply chain ...
Breaking Medicine Technology: